title: BET 2: Tadalafil medical expulsive therapy in ureteral calculi: a new kid on the block?
abstract: A short cut review was carried out to see if tadalafil, a phosphodiesterase type-5 (PDE5) inhibitor, was superior to standard α-adrenergic antagonists at promoting spontaneous ureteric calculi excretion. Two relevant papers were found, published by the same research group. The author, date and country of publication, patient group studied, study type, relevant outcomes, results study weaknesses of these papers are tabulated. Tadalafil was not shown to have significant superiority in terms of efficacy or adverse effects compared with standard treatment.
authors.affiliation: Grand Rapids Medical Education Research Partners/Michigan State University, Michigan, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Christie
authors.affiliation: Grand Rapids Medical Education Research Partners/Michigan State University, Michigan, USA.
authors.forename: Adam
authors.initials: A
authors.lastname: Oostema
mesh_terms: D006801:Humans; D000068581:Tadalafil / Q000627:therapeutic use*; D014514:Ureteral Calculi / Q000188:drug therapy*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D064804:Urological Agents; D000068581:Tadalafil